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Abstract. Lung and colon cancers are two of the most 
common malignancies, which, in some cases, may develop 
synchronously. In the present study, the treatment and outcome 
of patients with synchronous lung and colon cancers were 
reviewed. During a 76-month study period, from April 2009 
up to July 2016, 17 (0.54%) of 3,102 patients with lung cancer 
were diagnosed with colon cancer within 1 month. Heavy 
smoking and obesity were not specific factors in these patients. 
A total of 9 patients succumbed to lung cancer during the 
study period. Survival in asymptomatic patients was longer 
compared with that in symptomatic patients (median survival, 
80 vs. 23.2 months, respectively; P=0.007). Although the inci-
dence of synchronous occurrence of these two cancers may 
be low, particularly in patients diagnosed incidentally, such 
patients should be treated accordingly. Future genetic and 
epidemiological studies are required to elucidate the potential 
connection between lung and colon cancer.
Introduction
Patients with lung cancer may develop other malignancies (1,2), 
as may those with colon cancer (3). Epidemiologically, it has 
been suggested that cigarette smoking is closely associated 
with an increased risk of cancer in various organs, including the 
lung and the colon (4,5). Lung cancer is primarily known to be 
associated with upper aerodigestive tract cancer, but its asso-
ciation with gastrointestinal cancer should not be overlooked. 
In fact, lung cancer appears to be one of the most common 
second primary cancers in patients with colon cancer (4). 
However, there are few reports of the treatment and outcome 
of patients with synchronous lung and colon cancers (6-8). 
Additionally, the treatments for these cancer patients and their 
outcomes are scarcely reported (6-8). To evaluate the clinical 
information, we herein review our experience with lung cancer 
patients who developed synchronous colon cancer.
Patients and methods
Patient classification and staging. The medical records and 
pathology reports of all lung cancer patients at the Division of 
Respiratory Medicine in our four tertiary hospitals between 
April 2009 and July 2016 were reviewed. The collected 
data included sex, age at diagnosis of colon and lung cancer, 
smoking history, comorbid diseases, histology and clinical 
stage of lung cancer, type of treatment and survival from the 
date of diagnosis of lung cancer. The symptomatic group of 
patients were defined as those with symptoms of either or both 
lung and colon cancers. In the present study, synchronous 
cancers were defined as those diagnosed within 1 month.
The asymptomatic group of patients were defined as those 
detected incidentally by mass screening during follow-up studies 
for diseases other than these two cancers, and during lung or 
colon cancer workup. The diagnoses of colon and lung cancer 
were confirmed pathologically in all the patients and the histo-
pathological cancer types were confirmed by the World Health 
Organization classification. Staging was performed according 
to the 7th edition of the International Union for Cancer Control 
TNM classification of malignant tumors (http://www.uicc.
org/sites/main/files/private/TNM_Classification_of_Malignant_
Tumours_Website_15%20MAy2011.pdf), using chest computed 
tomography (CT), brain magnetic resonance imaging, bone 
scan, endoscopy and ultrasonography. In a proportion of the 
cases, fluorodeoxyglucose (FDG)-positron emission tomog-
raphy (PET) was used.
Statistical analysis. The statistical significance of the differ-
ences between the symptomatic and asymptomatic patient 
groups were determined using the Mann‑Whitney and 
Chi-squared test. Survival curves were assessed with the 
Kaplan-Meier method and the log-rank test. Survival was 
defined as the time from the initiation of the first therapy or 
supportive care until death or the last follow-up and was calcu-
lated in months. The effects of clinicopathological factors on 
survival were analyzed with the Cox proportional hazards 
model. Statistical analyses were performed using SPSS 10.1 
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for Windows (SPSS Inc., Chicago, IL, USA) and P<0.05 was 
considered to indicate statistically significant differences. 
Access to the patients' medical records was approved by the 
Ethics Committee of Mito Medical Center at the University of 
Tsukuba Hospital (NO16-01).
Results
Patient characteristics. During the study period, from April 
2009 up to July 2016, 17 (0.54%) of 3,102 patients with primary 
lung cancer were diagnosed with synchronous colon cancer. 
The clinicopathological characteristics of the 17 patients 
with synchronous lung and colon cancers are summarized in 
Table I. Of the 17 patients, 13 were male. The median age at 
diagnosis was 72 years (range, 60-86 years). Of the 17 patients, 
13 (76.5%) were smokers and 11 were >30-pack-year smokers. 
Only 2 (11.8%) of the patients were overweight [body mass 
index (BMI) ≥25.0 kg/m2] at the time of diagnosis of the two 
cancers. A total of 13 patients had non-small-cell lung cancer 
(NSCLS), and 15 (88.2%) had sigmoid colon or rectal cancer.
Treatment and outcome. In the 17 patients with synchronous 
lung and colon cancers, 9 patients were asymptomatic and 
the remaining 8 were symptomatic. The clinical stage and 
treatment for these two cancers in the two patient groups are 
summarized in Table II. Apart from the treatment for colon 
cancer, there were no statistically significant differences 
between the two groups. The numbers of patients who received 
therapy for colon cancer first, those who received therapy for 
lung cancer first, and those who received supportive care alone, 
are listed in Table III. There was no statistically significant 
difference between the two groups of patients.
During the study period, 9 patients succumbed to their 
disease. The cause of death in all 9 patients was directly 
associated with lung cancer. The median survival in the 
asymptomatic group of patients was 80 months and that in the 
symptomatic group of patients 23.2 months. The difference in 
survival between the two groups of patients was statistically 
significant (P=0.007; Fig. 1).
Table II. Differences between SCLC patients with and without 
ILD. 
 Patients Patients
 with without
Variables ILD ILD P-value
Age   0.489
  Median, range (years) 68, 5880 70, 27-86
Sex   0.999
  Male 14 280
  Female 1 37
Performance status   0.999
  0-1 13 265
  2-4 2 52
Clinical stage   0.999
  Early 7 152
  Advanced 8 165
Treatment   0.079
  Chemotherapy 13 263
  Surgery + chemotherapy 2 24
  Chest irradiation 0 25
  Supportive care 0 5
SCLC, smallcell lung cancer; ILD, interstitial lung disease.
Table I. Characteristics of 17 patients with synchronous lung 
and colon cancers.
Characteristics No. (%)
Age (years)
  Median, range  72, 60-86
Sex
  Male 13 (76.5)
  Female 4 (23.5)
Smoking habit
  Former- or current smoker 13 (76.5)
  Never smoker 4 (23.5)
Body mass index (kg/m2)
  ≥20 14 (82.4)
  ≥25 2 (11.8)
Lung cancer
  Non-smallcell lung cancer 13 (76.5)
  Smallcell lung cancer 4 (23.5)
Colorectal cancer
  Sigmoid colon or rectal cancer 15 (88.2)
  Others 2 (11.8)
Disease detection
  Asymptomatica 276 (86.5)
  Symptomatic 43 (13.5)
aDetected by mass screening during a follow-up survey for diseases 
other than lung and colon cancer.
Figure 1. Comparison of survival between asymptomatic patients (upper line) 
and symptomatic patients (lower line). There was a statistically significant 
difference in survival between the two groups of patients (P=0.007).
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Discussion
Lung cancer and colon cancer are two of the most common 
malignancies and among the leading causes of cancer-related 
mortality (9). Particularly in developed countries, these cancers 
are a major public health burden (9). There is a possibility 
that this combination may be more common than initially 
considered, if endoscopically treatable early colon cancer is 
taken into consideration. It is generally accepted that cigarette 
smoking plays an important role in lung carcinogenesis (4). In 
addition, epidemiological data suggested that obesity is asso-
ciated with an increased risk of colon cancer (10). Diabetes 
and high dietary meat intake are also associated with an 
increased risk of colon cancer (11). In the present study, there 
were 4 notable findings: First, we identified that 17 (0.54%) 
of 3,102 patients with lung cancer had synchronous colon 
cancer. In the present study, 13 (76.5%) of the 17 patients were 
smokers, 11 of whom were >30-pack-year smokers. However, 
only 5 (29.4%) had one of two smoking-related histological 
types of lung cancer, namely squamous cell carcinoma and 
small-cell lung carcinoma (SCLC). In addition, only 2 (11.8%) 
patients were overweight (BMI ≥25.0 kg/m2) at the time of 
diagnosis. These results suggested that several known and 
unknown factors may exhibit a complex association with 
the synchronous development of these two common cancers. 
Second, 15 (88.2%) of the 17 patients had colon cancer at the 
lower part of the large intestine, namely rectal cancer (n=8) 
and sigmoid cancer (n=7). Metastases from lung cancer to the 
descending colon and rectum are extremely rare, although 
there have been some case reports (12,13). However, it is 
generally accepted that these lower parts of the large intes-
tine are the most common sites where primary colon cancer 
develops (14). Third, the cause of death of the 9 patients 
who succumbed to the disease during the study period were 
directly associated with primary lung cancer (7 NSCLCs and 
2 SCLCs). Excluding 3 patients who were lost to follow-up, 
4 of the 5 patients who remain alive underwent surgical resec-
tion of lung cancer. Our results suggested that lung cancer is 
more likely to be the primary prognostic cancer rather than 
colon cancer. However, appropriate evaluation of the clinical 
stage is crucial for determining the optimal therapeutic 
strategy and predicting the patients' prognosis. It has not been 
fully elucidated why the prognosis of symptomatic patients 
was poorer compared with that of asymptomatic patients. It 
was hypothesized that the lung cancers in the latter group 
were more slow-growing. The limited number of patients and 
the short period of follow-up may have affected the results. 
Fourth, among the 17 patients, two colon cancers (1 rectal and 
one sigmoid colon cancer), were detected by PET/CT during 
the workup of primary lung cancer. Pezzuto et al also reported 
a case exhibiting FDG uptake on PET/CT (15). New diagnostic 
modalities, such as PET/CT, may provide important clinical 
information for patients with this rare condition (16,17).
There were certain limitations to the present study: The 
study was conducted only on a database of lung cancer patients, 
whereas it should also be conducted on a database of colon 
cancer patients. In addition, the retrospective design limits 
the generalization of the results. In light of our experience, it 
is appropriate to consider heightened surveillance of patients 
with synchronous lung and colon cancers, as early diagnosis 
and standard therapy are the only chance for long-term 
survival and cure. Swift evaluation of signs or symptoms that 
are suggestive not only of lung cancer but also of colon cancer 
is recommended. Although the incidence of synchronous lung 
and colon cancers may be low, future genetic and epidemiolog-
ical studies are required to elucidate the potential connection 
between these two types of cancer.
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